These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

774 related items for PubMed ID: 17603706

  • 1. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE, Al-Bayatti AA, Al-Ajeel AI, Al-Bahar AJ, Al-Nuaimy AA.
    Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
    [Abstract] [Full Text] [Related]

  • 2. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS, Lin Y, Zhang CH, Xu H, Li YF, Zhang SC, Tan Y, Quan S, Xing FQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
    [Abstract] [Full Text] [Related]

  • 3. Which hormone tests for the diagnosis of polycystic ovary syndrome?
    Robinson S, Rodin DA, Deacon A, Wheeler MJ, Clayton RN.
    Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
    [Abstract] [Full Text] [Related]

  • 4. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Mar; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 5. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA, Kerimoglu OS, Pekin AT, Incesu F, Dogan NU, Celik C, Unlu A.
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [Abstract] [Full Text] [Related]

  • 6. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
    Esmaeilzadeh S, Andarieh MG, Ghadimi R, Delavar MA.
    Glob J Health Sci; 2014 Sep 28; 7(2):101-6. PubMed ID: 25716399
    [Abstract] [Full Text] [Related]

  • 7. Endocrine changes after laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovarian syndrome.
    Al-Ojaimi EH.
    Saudi Med J; 2004 Aug 28; 25(8):1032-9. PubMed ID: 15322594
    [Abstract] [Full Text] [Related]

  • 8. [LH-FSH ratio and Polycystic Ovary Syndrome: A forgotten test?].
    Saucedo de la Llata E, Moraga-Sánchez MR, Romeu-Sarrió A, Carmona-Ruiz IO.
    Ginecol Obstet Mex; 2016 Feb 28; 84(2):84-94. PubMed ID: 27290835
    [Abstract] [Full Text] [Related]

  • 9. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec 28; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 10. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S, van der Spuy ZM.
    Ultrasound Obstet Gynecol; 1996 May 28; 7(5):335-41. PubMed ID: 8774098
    [Abstract] [Full Text] [Related]

  • 11. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.
    Timpatanapong P, Rojanasakul A.
    J Dermatol; 1997 Apr 28; 24(4):223-9. PubMed ID: 9164062
    [Abstract] [Full Text] [Related]

  • 12. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE.
    J Clin Endocrinol Metab; 1997 Jul 28; 82(7):2248-56. PubMed ID: 9215302
    [Abstract] [Full Text] [Related]

  • 13. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A, Laughlin GA, Morales AJ, Yen SS.
    J Clin Endocrinol Metab; 1997 Nov 28; 82(11):3728-33. PubMed ID: 9360532
    [Abstract] [Full Text] [Related]

  • 14. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B, Radzikowska M, Wasilewska-Dziubińska E, Kapliński A, Roguski K, Płonowski A.
    Gynecol Endocrinol; 1999 Oct 28; 13(5):344-51. PubMed ID: 10599552
    [Abstract] [Full Text] [Related]

  • 15. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y, Wei LN, Xiong YL, Liang XY.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug 28; 45(8):567-70. PubMed ID: 21029609
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.
    Katsikis I, Karkanaki A, Misichronis G, Delkos D, Kandaraki EA, Panidis D.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun 28; 156(2):181-5. PubMed ID: 21353371
    [Abstract] [Full Text] [Related]

  • 17. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.
    Cortet-Rudelli C, Pigny P, Decanter C, Leroy M, Maunoury-Lefebvre C, Thomas-Desrousseaux P, Dewailly D.
    Fertil Steril; 2002 Feb 28; 77(2):281-7. PubMed ID: 11821084
    [Abstract] [Full Text] [Related]

  • 18. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov 28; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 19. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
    Banaszewska B, Spaczyński RZ, Pelesz M, Pawelczyk L.
    Rocz Akad Med Bialymst; 2003 Nov 28; 48():131-4. PubMed ID: 14737959
    [Abstract] [Full Text] [Related]

  • 20. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb 28; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.